 |
 |

Detection of Cerebral Degeneration in Amyotrophic Lateral Sclerosis Using High-Field Magnetic Resonance Spectroscopy
Sanjay Kalra, MD;
Christopher C. Hanstock, PhD;
W. R. Wayne Martin, MD;
Peter S. Allen, PhD;
Wendy S. Johnston, MD
Arch Neurol. 2006;63:1144-1148.
Background Clinical assessment is insensitive to the degree of cerebral involvement in amyotrophic lateral sclerosis (ALS). Regional brain concentrations N-acetylaspartylglutamate (NAA) plus myo-inositol (Ins), as measured by magnetic resonance spectroscopy, are respectively decreased and increased, suggesting that these compounds may provide a biomarker of the degree of cerebral involvement in ALS.
Objective To test the hypothesis that the NAA/Ins ratio may provide an index of cerebral involvement in patients with ALS.
Design High-field (3.0-T) magnetic resonance spectroscopy was performed to determine the NAA/creatine plus phosphocreatine (NAA/Cr), NAA/choline (NAA/Cho), Ins/Cr, and NAA/Ins ratios in the motor cortex.
Participants Seventeen patients with ALS and 15 healthy control subjects were studied.
Results In patients with ALS, the greatest abnormality was a 22% decrease in NAA/Ins (71% sensitivity and 93% specificity, P = .001); Ins/Cr was increased 18% (88% sensitivity and 53% specificity, P = .04), NAA/Cr was decreased 10% (88% sensitivity and 47% specificity, P = .04), and NAA/Cho was decreased 14% (53% sensitivity and 87% specificity, P = .047). Correlation of the ALS Functional Rating Scale with NAA/Ins approached statistical significance (R = 0.43, P = .07).
Conclusion The NAA/Ins ratio may provide a meaningful biomarker in ALS given its optimal sensitivity and specificity profile.
Author Affiliations: Division of Neurology, Department of Medicine (Drs Kalra, Martin, and Johnston), and Department of Biomedical Engineering (Drs Hanstock and Allen), University of Alberta, Edmonton.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
|